Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many urologists remain unaware of their full potential to streamline practice ...

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...

Real Housewives of Beverly Hills alum Teddi Mellencamp shared an update on the side effects of her cancer treatments, less ...

Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...

The OPTIMUM study found 4.5% more clinically significant cancers among men who underwent micro-ultrasound–guided biopsies of ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

Dr. Dan Sperling As a radiologist specializing in prostate cancer diagnosis and treatment, I’m writing to share a fear I often hear from my patients. “Will this treatment affect my sex life?” This ...